An Acid-Hydrolyzed Wheat Protein Activates the Inflammatory and NF

Total Page:16

File Type:pdf, Size:1020Kb

An Acid-Hydrolyzed Wheat Protein Activates the Inflammatory and NF The Journal of Toxicological Sciences (J. Toxicol. Sci.) 327 Vol.45, No.6, 327-337, 2020 Letter An acid-hydrolyzed wheat protein activates the inflammatory and NF-κB pathways leading to long TSLP transcription in human keratinocytes Yasutaka Kuroda1,2, Takuo Yuki1, Yutaka Takahashi1, Hitoshi Sakaguchi1, Kayoko Matsunaga3 and Hiroshi Itagaki2,4 1Safety Science Research Laboratories, Kao Corporation, 2606, Akabane, Ichikai, Haga, Tochigi, Japan 2Department of Material Science and Engineering, Faculty of Engineering, Yokohama National University, 79-5, Tokiwadai, Hodogaya-ku, Yokohama, Kanagawa, Japan 3Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, 3-6-10, Otobashi, Nakagawa-ku, Nagoya, Aichi, Japan 4ITACS Consulting, 5-11-19-2504, Minamidai, Minami-ku, Sagamihara, Kanagawa, Japan (Received August 19, 2019; Accepted March 16, 2020) ABSTRACT — Hydrolyzed wheat proteins (HWPs) contained in cosmetics have occasionally caused immediate-type hypersensitivity following repeated skin exposure. Although the Cosmetic Ingredient Review Expert Panel concluded that < 3,500 Da HWP is safe for use in cosmetics, it remains biological- ly unknown how allergenic HWPs evoke immediate-type allergy percutaneously. Keratinocyte-derived thymic stromal lymphopoietin (TSLP) induces type 2 immune responses, which play an essential role in the pathogenesis of immediate-type allergy. Previously, we demonstrated that protein allergens in cultured human keratinocytes strongly induced long-form TSLP (loTSLP) transcription. However loTSLP-regulat- ing signaling by HWP is poorly understood. In this study, we performed global gene expression analysis by microarray to investigate how the allergenic HWP acts on epidermal keratinocytes and the induction of loTSLP. Compared to human serum albumin (HSA), allergenic HWP induced a distinct gene expression pattern and preferentially activated various inflammatory pathways (High Mobility Group Box 1, Inter- leukin [IL]-6, IL-8, and acute phase response signaling). We identified 85 genes as potential nuclear fac- tor-kappa B (NF-κB) target genes in GP19S-treated cells, compared with 29 such genes in HSA-treat- ed cells. In addition, HWP specifically altered IL-17 signaling pathways in which transcription factors, NF-κB and activator protein-1, were activated. NF-κB signaling may be an important factor for HWP- induced inflammatory loTSLP transcription via inhibition assay. In conclusion, allergenic HWP caused an easily sensitizable milieu of activated inflammatory pathways and induced NF-κB-dependent loTSLP transcription in keratinocytes. Key words: Hydrolyzed wheat protein, Keratinocytes, Thymic stromal lymphopoietin, Nuclear factor-kappa B INTRODUCTION diate-type allergy outbreak which was associated with the use of facial soap in Japan (Fukutomi et al., 2011; Hydrolyzed wheat proteins (HWPs) have been wide- Yagami et al., 2017). More recently Noguchi et al. (2019) ly used in shampoos, conditioners, and moisturizers that reported that Japanese GP19S allergy strongly associated are exposed to the skin. However, increasing evidence with HLA-DQ variants but not with FLG loss-of-function suggests that certain HWPs in cosmetics can cause con- mutation in genome-wide association study. Conversely, tact urticaria or anaphylaxis (Niinimäki et al., 1998; several comparative studies among GP19S, other HWPs, Varjonen et al., 2000; Laurière et al., 2006). In particu- and native gluten were conducted, and GP19S was found lar, acid-HWP, Glupearl 19S® (GP19S), caused an imme- to contain novel epitopes and high molecular weight anti- Correspondence: Yasutaka Kuroda (E-mail: [email protected]) Vol. 45 No. 6 328 Y. Kuroda et al. gens (Nakamura et al., 2013, 2016; Yokooji et al., 2013). ertheless, little is known about the mechanisms of loTSLP Our previous study, as well as others studies, demon- transcription in epidermal keratinocytes. More recent- strated that compared with native gluten, GP19S pos- ly, Redhu et al. (2020) reported four NF-κB binding sites sess higher allergenic potential than native gluten in mice were located in the human TSLP promoter region, and and guinea pig models (Adachi et al., 2012; Matsunaga IL-1α promoted NF-κB recruitment to two active bind- et al., 2015). In addition to host susceptibility, higher ing sites in human keratinocytes. In same setting, loTSLP allergenicity of HWP itself may be vital for GP19S aller- mRNA was significantly augmented. Therefore, the bind- gy. Although the Cosmetic Ingredient Review Expert ing NF-κB to these binding sites may important for loT- Panel concluded that < 3,500 Da HWP was safe for use SLP mRNA induction. in cosmetics (Belsito et al., 2014; Burnett et al., 2018), In this study, we performed comprehensive gene it remains biologically unknown how allergenic HWPs, expression analysis to demonstrate the potential for bio- such as GP19S, evoke immediate-type allergy via the logical predisposition to skin sensitization and induction skin route. of loTSLP by allergenic HWP. This study provides mech- Generally, an immediate-type allergy becomes sen- anistic insights into how highly allergenic proteins acts on sitized by the antigen-uptake of antigen-presenting cells epidermal keratinocytes. and antigen presentation to naïve T cells, leading to type 2 helper T (TH2) cell expansion, development of T fol- MATERIALS AND METHODS licular helper cells, and IgE production. In the skin, an epithelial cell-derived cytokine, namely thymic strom- Cells al lymphopoietin (TSLP), acts as a type 2 immunity pro- Primary human neonatal keratinocytes (Thermo Fisher moting factor. High TSLP levels were detected at the Scientific/Life Technologies, Waltham, MA, USA) were lesion sites of patients with atopic dermatitis and asthma, cultured in HuMedia KG2 (Kurabo, Osaka, Japan) and which mediated type 2 immunity (Soumelis et al., 2002; seeded at 4.5 × 104 cells/well in flat-bottomed, 24-well Shikotra et al., 2012). In addition, TSLP receptor sign- culture plates. Once the cells reached 80% confluence aling in Langerhans cells was essential for percutaneous (2-3 days after plating), the medium was replaced with sensitization with protein allergen and TH2-type immune HuMedia KG2, without hydrocortisone, in 24 hr accord- response in a murine model (Nakajima et al., 2012). We ing to Kinoshita et al. (2009)’s procedure. The cells that recently reported that highly allergenic proteins, includ- were passaged once were used for the assays. ing GP19S, induced the long form of TSLP (loTSLP) in epidermal keratinocytes (Kuroda et al., 2017). TSLP has Preparation of the exposure samples two transcription variants. loTSLP plays a vital role in GP19S, a product of wheat gluten obtained by par- type 2 immune response-related allergic diseases, includ- tial hydrolysis with hydrogen chloride (HCl) at 95°C for ing atopic dermatitis, allergic rhinitis, and asthma. The 40 min, was supplied by Katayama Chemical, Inc. short form of TSLP (shTSLP) is constitutively expressed (Osaka, Japan). GP19S was suspended in 1 M tris at both mRNA and protein levels in the skin of healthy (hydroxymethyl) aminomethane (Tris) solution (pH 11.4). subjects and have anti-inflammatory property (Bjerkan After 24 hr at room temperature, the samples were neutral- et al., 2015; Fornasa et al., 2015). shTSLP is related to ized with HCl by a previously reported method (Adachi et homeostatic functions in the thymus and gut (Tsilingiri al., 2012). A control vehicle sample (Tris-HCl) was pre- et al., 2017). Therefore, specific analysis of loTSLP is pared by neutralizing Tris with HCl. Human serum albu- essential for detecting inflammatory responses. However min (HSA; A5843, Sigma, St. Louis, MO, USA), with a the most studies have reported that the regulatory mech- confirmed endotoxin limit of 1.0 unit/mg, was dissolved in anisms of TSLP expression were analyzed as total-TSLP. phosphate-buffered saline (PBS, pH 7.2; Wako Chemical, Entire TSLP induction is regulated by NF-κB and acti- Osaka). Nuclear factor-kappa B (NF-κB) activa- vator protein 1 (AP-1) (Takai, 2012). In airway epitheli- tion inhibitors, 4-methyl-N1-(3-phenylpropyl)ben- al cells, IL-1β, and TNF-α-activated TSLP gene expres- zene-1,2-diamine (JSH-23; Merck KGaA, Darmstadt, sion was promoted by the upstream NF-κB site (Lee and Germany), and (1aR,4E,7aS,10aS,10bR)- Ziegler, 2007). In the airway’s smooth muscle cells, 2,3,6,7,7a,8,10a,10b-Octahydro-1a,5-dimethyl-8-meth- IgE-induced TSLP promoter activation was mediated ylene-oxireno[9,10] cyclodeca[1,2-b]furan-9(1aH)-one by NF-κB and AP-1 (Redhu et al., 2011). Furthermore, (Parthenolide; Sigma) were dissolved in dimethyl sul- TSLP promoter region contained NF-κB, AP-1, STAT, foxide (DMSO, Sigma-Aldrich, St. Louis, MO, USA) and Smad binding sites in mice (Ganti et al., 2017). Nev- at concentrations of 3 and 10 μM, respectively. Another Vol. 45 No. 6 329 HWP activates inflammatory and NF-kappaB pathways leading to loTSLP NF-κB activation inhibitor, ammonium pyrrolidine dithi- Real-time quantitative PCR analysis ocarbamate (PDTC; Sigma), was dissolved in PBS at a Real-time PCR analysis was performed using the concentration of 100 μM. The effectiveness of inhibi- TaqMan® Universal PCR Master Mix and Applied tor concentrations was verified in the paper by Inman et Biosystems® 7500 Fast Real-Time PCR System al. (2008), Dommisch et al. (2010), and Galbiati et al. (Thermo Fisher Scientific). The total-TSLP (toTSLP) (2011). and β-actin transcription levels were analyzed using
Recommended publications
  • Therapeutic and Prophylactic Use of Oral, Low-Dose Ifns in Species of Veterinary Interest: Back to the Future
    veterinary sciences Review Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future Sara Frazzini 1 , Federica Riva 2,* and Massimo Amadori 3 1 Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy; [email protected] 2 Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, 26900 Lodi, Italy 3 Rete Nazionale di Immunologia Veterinaria, 25125 Brescia, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0250334519 Abstract: Cytokines are important molecules that orchestrate the immune response. Given their role, cytokines have been explored as drugs in immunotherapy in the fight against different pathological conditions such as bacterial and viral infections, autoimmune diseases, transplantation and cancer. One of the problems related to their administration consists in the definition of the correct dose to avoid severe side effects. In the 70s and 80s different studies demonstrated the efficacy of cytokines in veterinary medicine, but soon the investigations were abandoned in favor of more profitable drugs such as antibiotics. Recently, the World Health Organization has deeply discouraged the use of antibiotics in order to reduce the spread of multi-drug resistant microorganisms. In this respect, the use of cytokines to prevent or ameliorate infectious diseases has been highlighted, and several studies show the potential of their use in therapy and prophylaxis also in the veterinary field. In this review we aim to review the principles of cytokine treatments, mainly IFNs, and to update the experiences encountered in animals. Keywords: veterinary immunotherapy; cytokines; IFN; low dose treatment; oral treatment Citation: Frazzini, S.; Riva, F.; Amadori, M.
    [Show full text]
  • IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis This information is current as Xin Zhang, Nazanin Kiapour, Sahil Kapoor, Tabish Khan, of September 27, 2021. Madhan Thamilarasan, Yazhong Tao, Stephanie Cohen, Ryan Miller, Raymond A. Sobel and Silva Markovic-Plese J Immunol published online 24 July 2019 http://www.jimmunol.org/content/early/2019/07/23/jimmun ol.1900311 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/07/23/jimmunol.190031 Material 1.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice Freely available online through The Journal of Immunology Author Choice option Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 24, 2019, doi:10.4049/jimmunol.1900311 The Journal of Immunology IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis Xin Zhang,* Nazanin Kiapour,* Sahil Kapoor,* Tabish Khan,* Madhan Thamilarasan,* Yazhong Tao,* Stephanie Cohen,† Ryan Miller,‡ Raymond A.
    [Show full text]
  • Cytokine Profiling in Myeloproliferative Neoplasms
    cells Review Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants 1,2, , 1, 1 3 3 Elena Masselli * y , Giulia Pozzi y, Giuliana Gobbi , Stefania Merighi , Stefania Gessi , Marco Vitale 1,2,* and Cecilia Carubbi 1 1 Department of Medicine and Surgery, Anatomy Unit, University of Parma, Via Gramsci 14, 43126 Parma, Italy; [email protected] (G.P.); [email protected] (G.G.); [email protected] (C.C.) 2 University Hospital of Parma, AOU-PR, Via Gramsci 14, 43126 Parma, Italy 3 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy; [email protected] (S.M.); [email protected] (S.G.) * Correspondence: [email protected] (E.M.); [email protected] (M.V.); Tel.: +39-052-190-6655 (E.M.); +39-052-103-3032 (M.V.) These authors contributed equally to this work. y Received: 1 September 2020; Accepted: 19 September 2020; Published: 21 September 2020 Abstract: Among hematologic malignancies, the classic Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) are considered a model of inflammation-related cancer development. In this context, the use of immune-modulating agents has recently expanded the MPN therapeutic scenario. Cytokines are key mediators of an auto-amplifying, detrimental cross-talk between the MPN clone and the tumor microenvironment represented by immune, stromal, and endothelial cells. This review focuses on recent advances in cytokine-profiling of MPN patients, analyzing different expression patterns among the three main Philadelphia-negative (Ph-negative) MPNs, as well as correlations with disease molecular profile, phenotype, progression, and outcome.
    [Show full text]
  • Evolutionary Divergence and Functions of the Human Interleukin (IL) Gene Family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W
    UPDATE ON GENE COMPLETIONS AND ANNOTATIONS Evolutionary divergence and functions of the human interleukin (IL) gene family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W. Nebert3* and Vasilis Vasiliou1 1Molecular Toxicology and Environmental Health Sciences Program, Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO 80045, USA 2Department of Clinical Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA 3Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267–0056, USA *Correspondence to: Tel: þ1 513 821 4664; Fax: þ1 513 558 0925; E-mail: [email protected]; [email protected] Date received (in revised form): 22nd September 2010 Abstract Cytokines play a very important role in nearly all aspects of inflammation and immunity. The term ‘interleukin’ (IL) has been used to describe a group of cytokines with complex immunomodulatory functions — including cell proliferation, maturation, migration and adhesion. These cytokines also play an important role in immune cell differentiation and activation. Determining the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response. ILs can also have pro- and anti-inflammatory effects, further complicating their characterisation. These molecules are under constant pressure to evolve due to continual competition between the host’s immune system and infecting organisms; as such, ILs have undergone significant evolution. This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organisation. Within the literature there are a number of overlapping nomenclature and classification systems derived from biological function, receptor-binding properties and originating cell type.
    [Show full text]
  • Cellular Vaccines Modified with Hyper IL6 Or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model
    ANTICANCER RESEARCH 35: 3275-3288 (2015) Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model JACEK MACKIEWICZ1,2.3, URSZULA KAZIMIERCZAK1, MAREK KOTLARSKI1, EWELINA DONDAJEWSKA1, ANNA KOZŁOWSKA1, ELIZA KWIATKOWSKA1,2, ANITA NOWICKA-KOTLARSKA1, HANNA DAMS-KOZŁOWSKA1,2, PIOTR JAN WYSOCKI1 and ANDRZEJ MACKIEWICZ1,2,4 1Medical Biotechnology, University of Medical Sciences, Poznan, Poland; 2Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland; 3Department of Medical and Experimental Oncology, Clinical Hospital of Poznan University of Medical Sciences, Poznan, Poland; 4BioContract Sp z o.o., Poznan, Poland Abstract. Background: Whole-cell-based vaccines modified present them in the context of major histocompatibility with Hyper-IL-6 (H6) and Hyper-IL-11 (H11) have complex (MHC) class I and II molecules into T-cells (3). demonstrated high activity in murine melanoma and renal Modification of vaccine cells with genes encoding cancer models. Materials and Methods: H6 and H11 cDNA immunostimulatory molecules, including cytokines, increases was transduced into TRAMP cells (TRAMP-H6 and TRAMP- their immunogenicity. H11). An orthotopic TRAMP model was employed. The Interleukin (IL) 6 and IL11 act on cells through IL6 efficacy of TRAMP-H6 and TRAMP-H11 in combination with receptor (IL6R) and IL11R complex, respectively. These docetaxel was evaluated. Immune cells infiltrating tumors receptors have similar structures. They consist of two were assessed. Results: Immunization with TRAMP-H6 and membrane-bound subunits, α, specific for IL6 or IL11, and β TRAMP-H11 vaccines extended OS of mice. Addition of (GP130) common for both. The β subunit is expressed on docetaxel to TRAMP-H6 and TRAMP-H11 vaccines further every human or animal cell (4), in contrast to α subunits, extended OS of the animals.
    [Show full text]
  • Techniques for Immune Function Analysis Application Handbook 1St Edition
    Techniques for Immune Function Analysis Application Handbook 1st Edition BD Biosciences For additional information please access the Immune Function Homepage at www.bdbiosciences.com/immune_function For Research Use Only. Not for use in diagnostic or therapeutic procedures. Purchase does not include or carry any right to resell or transfer this product either as a stand-alone product or as a component of another product. Any use of this product other than the permitted use without the express written authorization of Becton Dickinson and Company is strictly prohibited. All applications are either tested in-house or reported in the literature. See Technical Data Sheets for details. BD, BD Logo and all other trademarks are the property of Becton, Dickinson and Company. ©2003 BD Table of Contents Preface . 4 Chapter 1: Immunofluorescent Staining of Cell Surface Molecules for Flow Cytometric Analysis . 9 Chapter 2: BD™ Cytometric Bead Array (CBA) Multiplexing Assays . 35 Chapter 3: BD™ DimerX MHC:Ig Proteins for the Analysis of Antigen-specific T Cells. 51 Chapter 4: Immunofluorescent Staining of Intracellular Molecules for Flow Cytometric Analysis . 61 Chapter 5: BD FastImmune™ Cytokine Flow Cytometry. 85 Chapter 6: BD™ ELISPOT Assays for Cells That Secrete Biological Response Modifiers . 109 Chapter 7: ELISA for Specifically Measuring the Levels of Cytokines, Chemokines, Inflammatory Mediators and their Receptors . 125 Chapter 8: BD OptEIA™ ELISA Sets and Kits for Quantitation of Analytes in Serum, Plasma, and Cell Culture Supernatants. 143 Chapter 9: BrdU Staining and Multiparameter Flow Cytometric Analysis of the Cell Cycle . 155 Chapter 10: Cell-based Assays for Biological Response Modifiers . 177 Chapter 11: BD RiboQuant™ Multi-Probe RNase Protection Assay System .
    [Show full text]
  • IL-11 Promotes the Treatment Efficacy of Hematopoietic Stem Cell
    OPEN Experimental & Molecular Medicine (2017) 49, e410; doi:10.1038/emm.2017.217 Official journal of the Korean Society for Biochemistry and Molecular Biology www.nature.com/emm ORIGINAL ARTICLE IL-11 promotes the treatment efficacy of hematopoietic stem cell transplant therapy in aplastic anemia model mice through a NF-κB/microRNA-204/ thrombopoietin regulatory axis Yan Wang, Zhi-yun Niu, Yu-jie Guo, Li-hua Wang, Feng-ru Lin and Jing-yu Zhang Hematopoietic stem cell (HSC) transplantation could be of therapeutic value for aplastic anemia (AA) patients, and immunosuppressants may facilitate the efficiency of the procedure. As anti-inflammatory cytokine interleukin-11 (IL-11) has a thrombopoietic effect, its use in cases of chronic bone marrow failure, such as AA, has been proposed to induce HSC function. However, the putative mechanisms that may support this process remain poorly defined. We found that decreased miR-204-5p levels were coincident with increased proliferation in mouse HSCs following exposure to IL-11 in vitro. Through inhibiting NF-кB activity, miR-204-5p repression was demonstrated to be a downstream effect of IL-11 signaling. miR-204-5p was shown to directly target thrombopoietin (TPO) via sequence-dependent 3′-UTR repression, indicating that this microRNA-dependent pathway could serve an essential role in supporting IL-11 functions in HSCs. Increased TPO expression in HSCs following IL-11 exposure could be mimicked or blocked by inhibiting or overexpressing miR-204-5p, respectively. Consistent with these in vitro findings, IL-11 promoted HSC engraftment in a mouse model of AA, an effect that was attenuated in cells overexpressing miR-204-5p.
    [Show full text]
  • Family Member in Teleost Fish Identification of a Novel IL-1 Cytokine
    Identification of a Novel IL-1 Cytokine Family Member in Teleost Fish Tiehui Wang, Steve Bird, Antonis Koussounadis, Jason W. Holland, Allison Carrington, Jun Zou and Christopher J. This information is current as Secombes of September 25, 2021. J Immunol 2009; 183:962-974; Prepublished online 24 June 2009; doi: 10.4049/jimmunol.0802953 http://www.jimmunol.org/content/183/2/962 Downloaded from References This article cites 66 articles, 10 of which you can access for free at: http://www.jimmunol.org/content/183/2/962.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Identification of a Novel IL-1 Cytokine Family Member in Teleost Fish1 Tiehui Wang,* Steve Bird,* Antonis Koussounadis,† Jason W. Holland,* Allison Carrington,* Jun Zou,* and Christopher J. Secombes2* A novel IL-1 family member (nIL-1F) has been discovered in fish, adding a further member to this cytokine family.
    [Show full text]
  • IL-17F Gene Rs763780 and IL-17A Rs2275913 Polymorphisms in Patients with Periodontitis
    International Journal of Environmental Research and Public Health Article IL-17F Gene rs763780 and IL-17A rs2275913 Polymorphisms in Patients with Periodontitis Małgorzata Mazurek-Mochol 1, Małgorzata Kozak 2, Damian Malinowski 3 , Krzysztof Safranow 4 and Andrzej Pawlik 5,* 1 Department of Periodontology, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] 2 Department of Prosthetics, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] 3 Department of Pharmacology, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] 4 Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] 5 Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland * Correspondence: [email protected] Abstract: Background: Periodontitis (PD) is a chronic inflammatory disease that can eventually lead to tooth loss. Genetic and environmental factors such as smoking are involved in the pathogenesis of PD. The development of PD is potentiated by various pathogens that induce an immune response leading to the production of cytokines, such as interleukin (IL)-17. The synthesis of IL-17 is influenced genetically. The polymorphisms in IL-17 gene may affect the synthesis of IL-17. The aim of this study was to examine the association between the IL-17F rs763780 and IL-17A rs2275913 polymorphisms and PD in non-smoking and smoking patients to check if these polymorphisms could be a risk factor Citation: Mazurek-Mochol, M.; for PD. Methods: The study enrolled 200 patients with PD (130 non-smokers and 70 smokers) and Kozak, M.; Malinowski, D.; Safranow, 160 control subjects (126 non-smokers and 34 smokers).
    [Show full text]
  • Human Cytokine Response Profiles
    Comprehensive Understanding of the Human Cytokine Response Profiles A. Background The current project aims to collect datasets profiling gene expression patterns of human cytokine treatment response from the NCBI GEO and EBI ArrayExpress databases. The Framework for Data Curation already hosted a list of candidate datasets. You will read the study design and sample annotations to select the relevant datasets and label the sample conditions to enable automatic analysis. If you want to build a new data collection project for your topic of interest instead of working on our existing cytokine project, please read section D. We will explain the cytokine project’s configurations to give you an example on creating your curation task. A.1. Cytokine Cytokines are a broad category of small proteins mediating cell signaling. Many cell types can release cytokines and receive cytokines from other producers through receptors on the cell surface. Despite some overlap in the literature terminology, we exclude chemokines, hormones, or growth factors, which are also essential cell signaling molecules. Meanwhile, we count two cytokines in the same family as the same if they share the same receptors. In this project, we will focus on the following families and use the member symbols as standard names (Table 1). Family Members (use these symbols as standard cytokine names) Colony-stimulating factor GCSF, GMCSF, MCSF Interferon IFNA, IFNB, IFNG Interleukin IL1, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL9, IL10, IL11, IL12, IL13, IL15, IL16, IL17, IL18, IL19, IL20, IL21, IL22, IL23, IL24, IL25, IL26, IL27, IL28, IL29, IL30, IL31, IL32, IL33, IL34, IL35, IL36, IL36RA, IL37, TSLP, LIF, OSM Tumor necrosis factor TNFA, LTA, LTB, CD40L, FASL, CD27L, CD30L, 41BBL, TRAIL, OPGL, APRIL, LIGHT, TWEAK, BAFF Unassigned TGFB, MIF Table 1.
    [Show full text]
  • The Potential Role of Interleukin-11 in Epithelial Ovarian Cancer
    J Cancer Sci Clin Ther 2019; 3 (1): 028-047 DOI: 10.26502/jcsct.5079017 Review Article The Potential Role of Interleukin-11 in Epithelial Ovarian Cancer Nikhil Arora1, Nuzhat Ahmed2,3,4, Rodney B. Luwor1* 1Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Victoria 3052, Australia 2Fiona Elsey Cancer Research Institute, Ballarat, Victoria 3353, Australia 3Federation University Australia, Ballarat, Victoria 3010, Australia 4The Hudson Institute of Medical Research, Victoria 3168, Australia *Corresponding Author: Dr. Rodney B. Luwor , Level 5, Clinical Sciences Building, Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia, Tel: Tel: +61 3 8344- 3027; Fax: +61 3 9347-6488; E-mail: [email protected] Received: 13 February 2019; Accepted: 21 February 2019; Published: 28 February 2019 Abstract Interleukin-11 (IL-11) has recently gained attention in cancer biology, and there is now an upsurge in IL-11 research with studies implicating a role of IL-11 in several human cancers of epithelial and hematopoietic origins. The identification of the pro-tumorigenic activities elicited by IL-11 has placed a new focus on generating therapeutic agents that will inhibit the IL-11 signaling pathway. However, the precise role of IL-11 signaling remains elusive in epithelial ovarian cancer (EOC). The purpose of this review is to describe the ovarian tumor microenvironment and delineate the possible sources and functions of IL-11 in EOC. Taking a holistic view of the dynamics of IL-11 in other cancer types, we have elucidated the potential role of IL-11 signaling in ovarian tumor cell biology and have also provided future recommendations to exactly decipher and target the signaling pathway in EOC.
    [Show full text]
  • RT² Profiler PCR Array (384-Well Format) Human Inflammatory Response & Autoimmunity
    RT² Profiler PCR Array (384-Well Format) Human Inflammatory Response & Autoimmunity Cat. no. 330231 PAHS-3803ZE For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 7900HT (384-well block), Format E ViiA™ 7 (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (384-well block) Format G Description The Human Inflammatory Response & Autoimmunity RT² Profiler PCR Array profiles the expression of 370 key genes involved in immune response during autoimmunity and inflammation. It represents the expression of inflammatory cytokines, chemokines, and their receptors. It also contains genes related to the production and metabolism of cytokines. Genes involved in cytokine-cytokine receptor interactions are as well as thoroughly researched panels of genes involved in the acute-phase, inflammatory, and humoral immune responses. Using real-time PCR, you can easily and reliably analyze the expression of a focused panel of genes related to autoimmunity and inflammation with this array. For further details, consult the RT² Profiler PCR Array Handbook. Sample & Assay Technologies Shipping and storage RT² Profiler PCR Arrays in formats E and G are shipped at ambient temperature, on dry ice, or blue ice packs depending on destination and accompanying products. For long term storage, keep plates at –20°C. Note: Ensure that you have the correct RT² Profiler PCR Array format for your real-time cycler (see table above). Note: Open the package and store
    [Show full text]